Ernesto Estrada, Samuel Vazquez, Jul 28, 2013
This document studies bid rigging in public procurement of generic drugs in Mexico. The study is based on the outcomes of a series of public auctions for generic drugs held in 52 different locations between 2003 and 2008. By applying price and market share screenings, we identify many drugs where lowest bids tend to be identical across auctions regardless of winner, location or contract volume; and market shares quickly converge over time. Additionally, bids dropped and the above pattern disappeared after aggressive entry or procurement consolidation occurred. These findings triggered a formal investigation by the Mexican antitrust agency of two of the largest families of drugs: insulin and saline solutions. These collusive patterns and other indirect evidence gathered during the investigation, led to issue a decision by the agency of illegal bid rigging in both cases. This decision was challenged before Mexican courts, which confirmed it.
Featured News
US Appeals Court Tosses FTC Order Over Intuit’s “Free” TurboTax Ads
Mar 22, 2026 by
CPI
Jury Finds Musk Liable for Misleading Twitter Shareholders During Takeover Fight
Mar 22, 2026 by
CPI
FTC Launches Healthcare Task Force to Sharpen Enforcement
Mar 22, 2026 by
CPI
White House Pushes Congress for National AI Law to Override State Rules
Mar 22, 2026 by
CPI
Anthropic Copyright Settlement Lawyers Cut Fee Request to $187.5 Million
Mar 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak